(Q48618437)

13 February 2018

title

Absolute and relative bioavailability of fentanyl buccal tablet and oral transmucosal fentanyl citrate (English)

1 reference

13 February 2018

0 references

1 reference

Mona Darwish

1

1 reference

13 February 2018

Mary Kirby

2

1 reference

13 February 2018

Philmore Robertson

3

1 reference

13 February 2018

William Tracewell

4

1 reference

13 February 2018

John G Jiang

5

1 reference

13 February 2018

publication date

1 March 2007

1 reference

13 February 2018

The Journal of Clinical Pharmacology

published in

1 reference

13 February 2018

volume

47

1 reference

13 February 2018

issue

3

1 reference

13 February 2018

page(s)

343-350

1 reference

13 February 2018

https://api.crossref.org/works/10.1177%2F0091270006297749

1 reference

Mechanistic studies on effervescent-induced permeability enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006297749

Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006297749

Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006297749

Breakthrough pain in cancer patients: pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006297749

Breakthrough pain: characteristics and impact in patients with cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006297749

Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006297749

Dose proportionality and pharmacokinetics of oral transmucosal fentanyl citrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006297749

Influence of hepatic and intestinal cytochrome P4503A activity on the acute disposition and effects of oral transmucosal fentanyl citrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006297749

Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006297749

21 January 2018

Identifiers

DOI

10.1177/0091270006297749

1 reference

13 February 2018

1 reference

13 February 2018